Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition
暂无分享,去创建一个
L. Joosten | M. Netea | Z. Fayad | H. Ploegh | R. Dijkhuizen | T. Reiner | E. Guccione | R. Duivenvoorden | A. Griffioen | C. Calcagno | P. Bomans | H. Friedrich | N. Sommerdijk | J. Ochando | W. Mulder | S. Hak | Yiming Zhao | Bram Priem | L. Willemsen | J. Bravo-Cordero | Carlos Pérez-Medina | A. Teunissen | A. V. Elsas | G. Prévot | Alexandros Marios Sofias | E. Kluza | M. Rashidian | V. Mourits | G. Soultanidis | Alexander Rialdi | Anu E. Meerwaldt | E. Fisher | M. Winther | J. Martino | E. M. V. Leeuwen | Emma D. Klein | A. V. Verschuur | Sheqouia A. Nauta | E. Zupančič | Roderick S. Oosterwijk | Mandy M. T. van Leent | J. Munitz | Karen A.M. de Jong | Y. C. Toner | Denis Torre | C. Pérez-Medina | Lisa Willemsen | E. V. Leeuwen | M. M. V. Leent
[1] K. Jeong,et al. Reference values of hematological and biochemical parameters in young-adult cynomolgus monkey (Macaca fascicularis) and rhesus monkey (Macaca mulatta) anesthetized with ketamine hydrochloride , 2019, Laboratory Animal Research.
[2] J. Vilo,et al. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update) , 2019, Nucleic Acids Res..
[3] D. DeNardo,et al. Macrophages as regulators of tumour immunity and immunotherapy , 2019, Nature Reviews Immunology.
[4] John M. Gaspar,et al. NGmerge: merging paired-end reads via novel empirically-derived models of sequencing errors , 2018, BMC Bioinformatics.
[5] F. Ginhoux,et al. Inhibiting Inflammation with Myeloid Cell‐Specific Nanobiologics Promotes Organ Transplant Acceptance , 2018, Immunity.
[6] L. Joosten,et al. Trained immunity as a novel therapeutic strategy , 2018, Current opinion in pharmacology.
[7] C. Bettegowda,et al. Current state of immunotherapy for glioblastoma , 2018, Nature Reviews Clinical Oncology.
[8] J. Kleeff,et al. Therapeutic developments in pancreatic cancer: current and future perspectives , 2018, Nature Reviews Gastroenterology & Hepatology.
[9] Bin Zhang,et al. Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates , 2018, Nature Biomedical Engineering.
[10] L. Joosten,et al. Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity , 2018, Cell.
[11] L. Joosten,et al. Hypothesis: stimulation of trained immunity as adjunctive immunotherapy in cancer , 2017, Journal of leukocyte biology.
[12] Nicholas A. Sinnott-Armstrong,et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues , 2017, Nature Methods.
[13] R. Weinberg,et al. Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells , 2017, The Journal of experimental medicine.
[14] P. Greenberg,et al. Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies. , 2017, Cancer cell.
[15] J. Wargo,et al. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy , 2017, Cell.
[16] Valerie A Longo,et al. Immune cell screening of a nanoparticle library improves atherosclerosis therapy , 2016, Proceedings of the National Academy of Sciences.
[17] L. Joosten,et al. Immunometabolic circuits in trained immunity. , 2016, Seminars in immunology.
[18] L. Zitvogel,et al. Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors. , 2016, Immunity.
[19] R. Xavier,et al. Trained immunity: A program of innate immune memory in health and disease , 2016, Science.
[20] M. Netea,et al. BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study. , 2015, The Journal of infectious diseases.
[21] Zahi A. Fayad,et al. PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles , 2015, The Journal of Nuclear Medicine.
[22] Qing-Yu He,et al. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization , 2015, Bioinform..
[23] Piet Demeester,et al. FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry data , 2015, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[24] P. Sharma,et al. The future of immune checkpoint therapy , 2015, Science.
[25] Howard Y. Chang,et al. ATAC‐seq: A Method for Assaying Chromatin Accessibility Genome‐Wide , 2015, Current protocols in molecular biology.
[26] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[27] Taku Kambayashi,et al. Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell? , 2014, Nature Reviews Immunology.
[28] Valerie A Longo,et al. A Modular Labeling Strategy for In Vivo PET and Near-Infrared Fluorescence Imaging of Nanoparticle Tumor Targeting , 2014, The Journal of Nuclear Medicine.
[29] L. Kiemeney,et al. Autophagy Controls BCG-Induced Trained Immunity and the Response to Intravesical BCG Therapy for Bladder Cancer , 2014, PLoS pathogens.
[30] M. Pfeffer,et al. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial , 2014, European heart journal.
[31] Howard Y. Chang,et al. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position , 2013, Nature Methods.
[32] Sean C. Bendall,et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia , 2013, Nature Biotechnology.
[33] M. Clarke,et al. Intravital multiphoton imaging reveals multicellular streaming as a crucial component of in vivo cell migration in human breast tumors , 2013, Intravital.
[34] D. Pardoll. Immunology beats cancer: a blueprint for successful translation , 2012, Nature Immunology.
[35] R. Xavier,et al. Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes , 2012, Proceedings of the National Academy of Sciences.
[36] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[37] Yuen-Joyce Liu,et al. Muramyl dipeptide and its derivatives: peptide adjuvant in immunological disorders and cancer therapy. , 2011, Current bioactive compounds.
[38] David L. Porter,et al. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia , 2011, Science Translational Medicine.
[39] M. Netea,et al. Trained immunity: a memory for innate host defense. , 2011, Cell host & microbe.
[40] Gaël Varoquaux,et al. Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..
[41] A. Tall,et al. ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation , 2010, Science.
[42] K. Craig,et al. Coding of facial expressions of pain in the laboratory mouse , 2010, Nature Methods.
[43] J. Cavaillon,et al. Resilience to bacterial infection: difference between species could be due to proteins in serum. , 2010, The Journal of infectious diseases.
[44] Jason S. Lewis,et al. Standardized methods for the production of high specific-activity zirconium-89. , 2009, Nuclear medicine and biology.
[45] P. Meyers. Muramyl tripeptide (mifamurtide) for the treatment of osteosarcoma , 2009, Expert review of anticancer therapy.
[46] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[47] Klaas Nicolay,et al. Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. , 2009, Accounts of chemical research.
[48] Clifford A. Meyer,et al. Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.
[49] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[50] D. Philpott,et al. Innate Immune Sensing of Microbes by Nod Proteins , 2006, Annals of the New York Academy of Sciences.
[51] S. Akira,et al. Pathogen Recognition and Innate Immunity , 2006, Cell.
[52] M. Drouet,et al. Nonhuman primates are relevant models for research in hematology, immunology and virology. , 2005, European cytokine network.
[53] Polly Matzinger,et al. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses , 2004, Nature Reviews Immunology.
[54] Z. Eshhar,et al. Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[55] J. Strominger,et al. A modified colorimetric method for the estimation of N-acetylamino sugars. , 1955, The Journal of biological chemistry.
[56] Vanessa M. Hubbard-Lucey,et al. Comprehensive analysis of the clinical immuno-oncology landscape , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.
[57] Tiffany J. Chen,et al. Cytobank: providing an analytics platform for community cytometry data analysis and collaboration. , 2014, Current topics in microbiology and immunology.
[58] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[59] K. P. Murphy,et al. Janeway's immunobiology , 2007 .
[60] C. Janeway,et al. Innate immune recognition. , 2002, Annual review of immunology.